Boston Oncology maintains a diverse and extensive portfolio of best-in-class generic and biosimilar therapeutics—USFDA / EMA registered and licensed from world-renowned innovator companies—supporting the entire patient journey.
We are very proud of our reputation for anticipating demand, and growing our portfolio with precision. Our products include the most widely used formulations in critical care, oncology, and pain relief—offering a comprehensive solution to healthcare providers and hospitals.
Leveraging our Global footprint and extensive International experience, Boston Oncology is able to secure licensing agreements for the best formulations in the US and European markets. We deliver products of unparalleled quality by creating modular and highly flexible local manufacturing facilities, sourcing API from the same batches manufactured for the US and European markets; and even pursuing regional approvals using the same files submitted for the original USFDA / EMA registration.
Boston Oncology is aggressively pursuing a research and development program to offer next generation treatments through critical care medicines, specialty generics, oncology products, orphan drugs, and narcotics.
3.5mg Powder for Solution
250mg Tablet
500mg Tablet
1 mg/mL Concentrate for Solution
50mg Film-Coated Tablet
70mg Film-Coated Tablet
100mg Film-Coated Tablet
500mg Powder for Solution
200mg Powder for Solution
1000mg Powder for Solution
1000mg Concentrate for Solution
20mg/mL Concentrate for Solution
80mg/mL Concentrate for Solution
2.5mg Film-Coated Tablet
50mg Powder for Solution
100mg Powder for Solution
20mg/mL Concentrate for Solution
60mg Tablet
24mg/mL Solution for Injection
0.1mg/mL Solution for Injection
1mg/mL Solution for Injection
10mg/mL Solution for Injection
100mg/mL Solution for Injection
30mg/mL Solution for Injection
100mg/mL Solution for Injection
90mg Film-Coated Tablet
180mg Film-Coated Tablet
360mg Film-Coated Tablet
150mg Powder for Solution
4mg Concentrate for Solution
50mg Powder for Concentrate for Solution
70mg Powder for Concentrate for Solution
350mg Powder for Solution
50mg/vial Powder for Solution
75mg Capsule
24mg/mL Solution for Infusion
100mg Powder for Concentrate for Solution
20mg Solution for Injection
40mg Solution for Injection
60mg Solution for Injection
80mg Solution for Injection